Suppr超能文献

在生理氧张力下从人类胚胎干细胞中获得高产量的少突胶质细胞系细胞,用于评估转化生物学。

High yields of oligodendrocyte lineage cells from human embryonic stem cells at physiological oxygen tensions for evaluation of translational biology.

机构信息

Department of Clinical Neurosciences, Cambridge University, Cambridge CB2 0PY, UK ; Wellcome Trust-Medical Research Council Cambridge Stem Cell Institute and Department of Veterinary Medicine, Cambridge University, Cambridge CB3 0ES, UK.

出版信息

Stem Cell Reports. 2013 Oct 31;1(5):437-50. doi: 10.1016/j.stemcr.2013.09.006. eCollection 2013.

Abstract

We have established and efficient system to specify NG2/PDGF-Rα/OLIG2+ oligodendrocyte precursor cells (OPCs) from human embryonic stem cells (hESCs) at low, physiological (3%) oxygen levels. This was achieved via both forebrain and spinal cord origins, with up to 98% of cells expressing NG2. Developmental insights reveal a critical role for fibroblast growth factor 2 (FGF-2) in OLIG2 induction via ventral forebrain pathways. The OPCs mature in vitro to express O4 (46%) and subsequently become galactocerebroside (GALC), O1, and myelin basic protein-positive (MBP+) multibranching oligodendrocytes. These were cultured alongside hESC-derived neurons. The electrophysiological properties of human OPCs are similar to those of rat OPCs, with large voltage-gated sodium currents and the ability to fire action potentials. Exposure to a selective retinoid X receptor agonist increased the proportion of O4+ oligodendrocytes that express MBP from 5% to 30%. Thus, we have established a developmentally engineered system to investigate the biological properties of human OPCs and test the effects of putative remyelinating agents prior to clinical application.

摘要

我们已经建立了一个有效的系统,可以在低氧(3%)水平下从人类胚胎干细胞(hESC)中特异性鉴定出 NG2/PDGF-Rα/OLIG2+少突胶质前体细胞(OPC)。这是通过前脑和脊髓起源实现的,高达 98%的细胞表达 NG2。发育见解揭示了成纤维细胞生长因子 2(FGF-2)通过腹侧前脑途径在 OLIG2 诱导中的关键作用。OPC 在体外成熟,表达 O4(46%),随后成为半乳糖脑苷脂(GALC)、O1 和髓鞘碱性蛋白阳性(MBP+)多分支少突胶质细胞。这些细胞与 hESC 衍生的神经元一起培养。人 OPC 的电生理特性与大鼠 OPC 相似,具有大的电压门控钠电流和产生动作电位的能力。暴露于选择性视黄酸受体激动剂可将表达 MBP 的 O4+少突胶质细胞的比例从 5%增加到 30%。因此,我们建立了一个发育工程系统,以研究人 OPC 的生物学特性,并在临床应用前测试潜在的髓鞘修复剂的效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e07d/3841262/cdc4e57a3869/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验